Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

530 trials

NCT06375122
Recruiting
Natural History Study of Kaposi Sarcoma
Not applicable · United States · 1 site
Registry update: 3 Nov 2026
NCT05726383
Recruiting
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Phase 2 · United States · 2 sites
Registry update: 4 Nov 2026
NCT06004011
Recruiting
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
Not applicable · Zambia · 1 site
Registry update: 4 Nov 2026
NCT06349642
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
Not applicable · United States · 3 sites
Registry update: 12 Mar 2026
NCT05917301
Recruiting
Pre-operative Hypofractionated Proton Therapy
Not applicable · United States · 1 site
Registry update: 17 Apr 2026
2022-501725-21-00
Recruiting
A phase I safety, dose finding and feasibility trial of GD2IL18CART in patients with relapsed or refractory GD2 positive solid cancers
Phase 1 · Germany · 4 sites
Registry update: 31 Aug 2026
NCT06235125
Recruiting
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Phase 1 · United States · 1 site
Registry update: 5 Jun 2026
NCT06272864
Recruiting
BostonGene and Exigent Genomic INsight Study
Not applicable · United States · 7 sites
Registry update: 17 Feb 2025
NCT06327477
Recruiting
Proton-Spatially Fractionated Radiotherapy and Standard Radiation Therapy for the Treatment of Newly Diagnosed Retroperitoneal Soft Tissue Sarcoma
Phase 1/2 · United States · 1 site
Registry update: 7 Jul 2026
NCT06375941
Recruiting
Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars
Not applicable · Italy · 19 sites
Registry update: 20 Nov 2025
NCT06239272
Recruiting
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Phase 1/2 · United States · 7 sites
Registry update: 3 Aug 2026
NCT06083883
Recruiting
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Phase 1 · United States · 1 site
Registry update: 29 Jul 2026
NCT06340204
Recruiting
Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Phase 1 · China · 3 sites
Registry update: 3 Apr 2024
NCT06384404
Recruiting
Upfront Surgical Resection for Osteosarcoma
Not applicable · United States · 1 site
Registry update: 16 Mar 2026
NCT06805669
Recruiting
This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
Not applicable · Canada · 1 site
Registry update: 3 Feb 2025
NCT06409013
Recruiting
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Not applicable · United States · 1 site
Registry update: 4 Aug 2026
NCT06023641
Recruiting
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Phase 2 · United States · 3 sites
Registry update: 15 Jun 2026
NCT06242470
Recruiting
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · Australia, United Kingdom, United States · 12 sites
Registry update: 28 Oct 2026
NCT05950594
Recruiting
IVIM & OLINK in Sarcoma
Phase 2 · Canada · 1 site
Registry update: 16 Mar 2026
NCT06176989
Recruiting
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Phase 2 · United States · 1 site
Registry update: 5 Nov 2026

Ordered by registry start date. Freshness and sponsorship never change the order.